However, a molecular sub-cluster of colon cancer cells is specifically sensitive to chemotherapy, BRAF inhibitors and PI3K-mTOR inhibitors treatment suggesting those drugs share some similar inner mechanisms to determine their sensitivity. The gene discussed is MTOR; the disease is malignant colon neoplasm.